320 related articles for article (PubMed ID: 26344651)
21. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
Oh YJ; Yang SH; Kim DK; Kang SW; Kim YS
PLoS One; 2013; 8(4):e62151. PubMed ID: 23637987
[TBL] [Abstract][Full Text] [Related]
22. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J
J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206
[TBL] [Abstract][Full Text] [Related]
23. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
[TBL] [Abstract][Full Text] [Related]
24. Membranous nephropathy with crescents: a series of 19 cases.
Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological Characteristics and Outcomes of PLA
Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
[TBL] [Abstract][Full Text] [Related]
26. Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.
Kattah A; Ayalon R; Beck LH; Sethi S; Sandor DG; Cosio FG; Gandhi MJ; Lorenz EC; Salant DJ; Fervenza FC
Am J Transplant; 2015 May; 15(5):1349-59. PubMed ID: 25766759
[TBL] [Abstract][Full Text] [Related]
27. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
28. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
29. Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy.
Hu X; Xu J; Wang W; Liu L; Jing Y; Gao C; Yu X; Li Y; Lin L; Tong J; Weng Q; Pan X; Zhang W; Ren H; Li G; Kiryluk K; Chen N; Xie J
Clin J Am Soc Nephrol; 2024 May; 19(5):573-582. PubMed ID: 38423528
[TBL] [Abstract][Full Text] [Related]
30. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
[TBL] [Abstract][Full Text] [Related]
31. Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome.
Duan S; Chen S; Chen C; Lu F; Pan Y; Lu Y; Li Q; Liu S; Zhang B; Mao H; Xing C; Yuan Y
Ren Fail; 2024 Dec; 46(1):2359024. PubMed ID: 38832491
[TBL] [Abstract][Full Text] [Related]
32. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
Hill PA; McRae JL; Dwyer KM
Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
[TBL] [Abstract][Full Text] [Related]
33. A Proposal for a Serology-Based Approach to Membranous Nephropathy.
De Vriese AS; Glassock RJ; Nath KA; Sethi S; Fervenza FC
J Am Soc Nephrol; 2017 Feb; 28(2):421-430. PubMed ID: 27777266
[TBL] [Abstract][Full Text] [Related]
34. [The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy].
Lin W; Li H; Li X; Qin Y; Su Y; Yu Y; Guan Y; Duan L; Li Y; Wen Y; Li X
Zhonghua Nei Ke Za Zhi; 2015 Sep; 54(9):783-8. PubMed ID: 26674797
[TBL] [Abstract][Full Text] [Related]
35. Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis.
Ong L; Silvestrini R; Chapman J; Fulcher DA; Lin MW
Pathology; 2016 Apr; 48(3):242-6. PubMed ID: 27020499
[TBL] [Abstract][Full Text] [Related]
36. [Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R].
Kozioł M; Sikora A; Kozioł-Montewka M; Smarz-Widelska I; Orłowska-Kowalik G; Pyszna W; Załuska W; Ksiazek A
Pol Merkur Lekarski; 2014 Mar; 36(213):171-4. PubMed ID: 24779214
[TBL] [Abstract][Full Text] [Related]
37. The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy.
Chen Y; Xu Y; Chen S; Yu Y; Zhu X; Chen J
Ren Fail; 2023; 45(2):2264939. PubMed ID: 37814415
[TBL] [Abstract][Full Text] [Related]
38. Membranous nephropathy in patients with HIV: a report of 11 cases.
Charu V; Andeen N; Walavalkar V; Lapasia J; Kim JY; Lin A; Sibley R; Higgins J; Troxell M; Kambham N
BMC Nephrol; 2020 Sep; 21(1):401. PubMed ID: 32948130
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.
Medrano AS; Escalante EJ; Cáceres CC; Pamplona IA; Allende MT; Terrades NR; Carmeno NV; Roldán EO; Agudelo KV; Vasquez JJ
Biomarkers; 2015 Feb; 20(1):77-83. PubMed ID: 25519165
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis.
Dai H; Zhang H; He Y
Sci Rep; 2015 Mar; 5():8803. PubMed ID: 25740009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
